Table 1: A summary of selected studies with different approaches to colon cancer.

Study

Key inclusion criteria

Treatment

Outcomes

Quasar

Stage II

Surgery + QT 5-FU + Folinic acid     vs.

Surgery + observation

Overall survival: 3.6% vs. 3.1%

Sacura

Stage II

Surgery + QT oral UFT during 1 year vs. surgery + observation

Ongoing

Mosaic

Stage III

5-FLU + Leucovorin vs. FOLFOX 4

DFS: 67.4% vs. 3.3%

Haller, et al. [62]

Stage III

XELOX vs. 5-FU + Folinic acid

Survival in 3 years: 70.9% vs. 66.7%

 

DFS: Disease Free Survival